101 related articles for article (PubMed ID: 17592263)
1. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E
Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes.
Insin P; Prueksaritanond N
Asian Pac J Cancer Prev; 2018 May; 19(5):1295-1302. PubMed ID: 29802690
[TBL] [Abstract][Full Text] [Related]
3. Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study.
Shim SH; Lim J; Kim JH; Lee YJ; Ha HI; Lim MC; Won YJ
J Gynecol Oncol; 2024 May; 35(3):e32. PubMed ID: 38130136
[TBL] [Abstract][Full Text] [Related]
4. Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.
Hagemann IS; Deng W; Zaino RJ; Powell MA; Gunderson Jackson C; Cosgrove C; Mathews C; Pearl ML; Waggoner S; Ghebre R; Lele S; Guntupalli S; Secord AA; Ioffe O; Rasty G; Singh M; Soslow R; Creasman W; Mutch DG
Gynecol Oncol; 2023 Oct; 177():38-45. PubMed ID: 37634258
[TBL] [Abstract][Full Text] [Related]
5. The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification.
Vrede SW; Hulsman AMC; Reijnen C; Van de Vijver K; Colas E; Mancebo G; Moiola CP; Gil-Moreno A; Huvila J; Koskas M; Weinberger V; Minar L; Jandakova E; Santacana M; Matias-Guiu X; Amant F; Snijders MPLM; Küsters-Vandevelde HVN; ; Bulten J; Pijnenborg JMA
Gynecol Oncol; 2022 Nov; 167(2):196-204. PubMed ID: 36096975
[TBL] [Abstract][Full Text] [Related]
6. FcRn Expression in Endometrial Cancer and Its Association with Clinicopathologic Features.
Song DH; Yang J; Kim CH; Kim MH; Jo JY; Baek JC
Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132243
[TBL] [Abstract][Full Text] [Related]
7. Association of Peritoneal Cytology with Other Prognostic Factors in Endometrial Cancer.
Maricic S; Mandic A; Vasiljević T; Gutic B; Stevanovic N; Maksimovic T
J Cytol; 2022; 39(4):155-158. PubMed ID: 36605867
[TBL] [Abstract][Full Text] [Related]
8. Uncommon Morphologic Types of Endometrial Cancer and Their Mimickers: How Much Does Molecular Classification Improve the Practice for Challenging Cases?
Saglam O
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541711
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and sonographic endometrial thickness as predictors of tumour stage and histological subtype of endometrial cancer.
Rizzuto I; Nicholson R; MacNab WS; Nalam M; Sharma R; Rufford B
Gynecol Oncol Rep; 2019 Nov; 30():100491. PubMed ID: 31508476
[TBL] [Abstract][Full Text] [Related]
10. Type II endometrial cancers: A case series.
Lobo FD; Thomas E
J Midlife Health; 2016; 7(2):69-72. PubMed ID: 27499593
[TBL] [Abstract][Full Text] [Related]
11. Trends in incidence and hormonal management of endometrial cancer during potentially reproductive age in Japan: a population-based study.
Sasano T; Mabuchi S; Komura N; Sakata M; Kamiura S; Morishima T; Miyashiro I
Int J Clin Oncol; 2024 May; ():. PubMed ID: 38762822
[TBL] [Abstract][Full Text] [Related]
12. The ErbB Signaling Network and Its Potential Role in Endometrial Cancer.
Androutsopoulos G; Styliara I; Zarogianni E; Lazurko N; Valasoulis G; Michail G; Adonakis G
Epigenomes; 2023 Oct; 7(4):. PubMed ID: 37873809
[TBL] [Abstract][Full Text] [Related]
13. Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study.
Farolfi A; Gentili N; Testoni S; Rusconi F; Massa I; Danesi V; Altavilla A; Cursano MC; Gurioli G; Burgio SL; Ibarburu GH; De Giorgi U
iScience; 2024 May; 27(5):109680. PubMed ID: 38646168
[TBL] [Abstract][Full Text] [Related]
14. Data-independent acquisition for proteomic applications in early-stage endometrial cancer progression.
Cheng Y; Xing Y; Du J; Hu D; Liang X; Liu C; Yang Y
J Obstet Gynaecol Res; 2024 Feb; 50(2):233-244. PubMed ID: 37984439
[TBL] [Abstract][Full Text] [Related]
15. Prognostic features of surgical stage I uterine carcinosarcoma.
Ferguson SE; Tornos C; Hummer A; Barakat RR; Soslow RA
Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221
[TBL] [Abstract][Full Text] [Related]
16. Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk?
Paudice M; Biatta CM; Scaglione G; Parodi A; Mammoliti S; Moioli M; Centurioni MG; Barra F; Ferrero S; De Cian F; Mazzocco K; Vellone VG
Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443564
[TBL] [Abstract][Full Text] [Related]
17. Type II endometrial cancer: Incidence, overall and disease-free survival in Martinique.
Ebring C; Marlin R; Macni J; Vallard A; Bergerac S; Beaubrun-Renard M; Joachim C; Jean-Laurent M
PLoS One; 2023; 18(3):e0278757. PubMed ID: 36928660
[TBL] [Abstract][Full Text] [Related]
18. Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas.
Zong L; Mo S; Sun Z; Lu Z; Chen J; Yu S; Xiang Y
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675462
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of carcinosarcoma from endometrial carcinoma on magnetic resonance imaging using deep learning.
Saida T; Mori K; Hoshiai S; Sakai M; Urushibara A; Ishiguro T; Satoh T; Nakajima T
Pol J Radiol; 2022; 87():e521-e529. PubMed ID: 36250139
[TBL] [Abstract][Full Text] [Related]
20. Clinical Implications of Genomic Loss of Heterozygosity in Endometrial Carcinoma.
Bustamante B; Sinha R; Rice B; Nizam A; Shan W; Goldberg GL; John V; Lin DI; Danziger N; Pavlick DC; Elvin JA; Frimer M
JCO Precis Oncol; 2021; 5():. PubMed ID: 34585039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
